Avista Capital to Acquire Bristol-Myers Squibb

share Share


Don Kiepert, the founder and former chairman, CEO and president of Point Therapeutics, will become the CEO of the, according to Avista.

«« Philips joins forces with Dubai Healthcare City and other leading Middle East healthcare providers to bring its vision of people-centered innovation to Arab Health 2008


FDA Advisory Panel Finds Hologic »»

Published on : Tue, 18 Dec 2007


Don Kiepert, the founder and former chairman, CEO and president of Point Therapeutics, will become the CEO of the, according to Avista.

No comment


Please login to leave a comment...

Highlighted Products